Effects of constraint-induced movement therapy on neurogenesis and functional recovery after early hypoxic-ischemic injury in mice

Dong Wook Rha, Seong Woong Kang, Yoon Ghil Park, Sung-Rae Cho, Won Taek Lee, Jongeun Lee, Chung Mo Nam, Kyung Hwa Han, Eun Sook Park

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Aim: Constraint-induced movement therapy (CIMT) has emerged as a promising therapeutic strategy for improving affected upper limb function in children with hemiplegic cerebral palsy (CP). However, little is known about the changes in the brain that are induced by CIMT. This study was designed to investigate these changes and behavioural performance after CIMT intervention in mice with neonatal hypoxic-ischemic brain injury. Method: We utilized the neonatal hypoxic-ischemic brain injury model established in mice pups. Three weeks after the injury, the mice were randomly assigned to the following three groups: the control group (n=15), the enriched-environment group (n=17), and the CIMT with an enriched-environment group (CIMT-EE, n=15). 5-bromo-2-deoxyuridine (BrdU) was injected daily to label proliferating cells during the 2 weeks of intervention. Results: The CIMT-EE group showed better fall rate in the horizontal ladder rung walking test (mean 5.4%, SD 3.6%) than either the control (mean 14.3%, SD 7.3%; p=0.001) or enriched-environment (mean 12.4%, SD 7.7%; p=0.010) groups 2 weeks after the end of intervention. The CIMT-EE group also showed more neurogenesis (mean 7069 cells/mm3, SD 4017 cells/mm3) than either the control group (mean 1555 cells/mm3, SD 1422 cells/mm3; p<0.001) or enriched-environment group (mean 2994 cells/mm3, SD 3498 cells/mm3; p=0.001) in the subventricular zone. In the striatum, neurogenesis in the CIMT-EE group (mean 534 cells/mm3, SD 441 cells/mm3) was greater than in the control group (mean 95 cells/mm3, SD 133 cells/mm3; p=0.001). Interpretation: There was CIMT-EE enhanced neurogenesis in the brain along with functional benefits in mice after early hypoxic-ischemic brain injury. This is the first study to demonstrate the effects of CIMT on neurogenesis and functional recovery after experimental injury to an immature brain.

Original languageEnglish
Pages (from-to)327-333
Number of pages7
JournalDevelopmental Medicine and Child Neurology
Volume53
Issue number4
DOIs
Publication statusPublished - 2011 Apr 1

Fingerprint

Neurogenesis
Wounds and Injuries
Group Psychotherapy
Therapeutics
Brain Injuries
Control Groups
Brain
Lateral Ventricles
Cerebral Palsy
Bromodeoxyuridine
Upper Extremity
Walking

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Rha, Dong Wook ; Kang, Seong Woong ; Park, Yoon Ghil ; Cho, Sung-Rae ; Lee, Won Taek ; Lee, Jongeun ; Nam, Chung Mo ; Han, Kyung Hwa ; Park, Eun Sook. / Effects of constraint-induced movement therapy on neurogenesis and functional recovery after early hypoxic-ischemic injury in mice. In: Developmental Medicine and Child Neurology. 2011 ; Vol. 53, No. 4. pp. 327-333.
@article{c096bcd90f8149929eb875d08ffd9101,
title = "Effects of constraint-induced movement therapy on neurogenesis and functional recovery after early hypoxic-ischemic injury in mice",
abstract = "Aim: Constraint-induced movement therapy (CIMT) has emerged as a promising therapeutic strategy for improving affected upper limb function in children with hemiplegic cerebral palsy (CP). However, little is known about the changes in the brain that are induced by CIMT. This study was designed to investigate these changes and behavioural performance after CIMT intervention in mice with neonatal hypoxic-ischemic brain injury. Method: We utilized the neonatal hypoxic-ischemic brain injury model established in mice pups. Three weeks after the injury, the mice were randomly assigned to the following three groups: the control group (n=15), the enriched-environment group (n=17), and the CIMT with an enriched-environment group (CIMT-EE, n=15). 5-bromo-2-deoxyuridine (BrdU) was injected daily to label proliferating cells during the 2 weeks of intervention. Results: The CIMT-EE group showed better fall rate in the horizontal ladder rung walking test (mean 5.4{\%}, SD 3.6{\%}) than either the control (mean 14.3{\%}, SD 7.3{\%}; p=0.001) or enriched-environment (mean 12.4{\%}, SD 7.7{\%}; p=0.010) groups 2 weeks after the end of intervention. The CIMT-EE group also showed more neurogenesis (mean 7069 cells/mm3, SD 4017 cells/mm3) than either the control group (mean 1555 cells/mm3, SD 1422 cells/mm3; p<0.001) or enriched-environment group (mean 2994 cells/mm3, SD 3498 cells/mm3; p=0.001) in the subventricular zone. In the striatum, neurogenesis in the CIMT-EE group (mean 534 cells/mm3, SD 441 cells/mm3) was greater than in the control group (mean 95 cells/mm3, SD 133 cells/mm3; p=0.001). Interpretation: There was CIMT-EE enhanced neurogenesis in the brain along with functional benefits in mice after early hypoxic-ischemic brain injury. This is the first study to demonstrate the effects of CIMT on neurogenesis and functional recovery after experimental injury to an immature brain.",
author = "Rha, {Dong Wook} and Kang, {Seong Woong} and Park, {Yoon Ghil} and Sung-Rae Cho and Lee, {Won Taek} and Jongeun Lee and Nam, {Chung Mo} and Han, {Kyung Hwa} and Park, {Eun Sook}",
year = "2011",
month = "4",
day = "1",
doi = "10.1111/j.1469-8749.2010.03877.x",
language = "English",
volume = "53",
pages = "327--333",
journal = "Developmental Medicine and Child Neurology",
issn = "0012-1622",
publisher = "Wiley-Blackwell",
number = "4",

}

Effects of constraint-induced movement therapy on neurogenesis and functional recovery after early hypoxic-ischemic injury in mice. / Rha, Dong Wook; Kang, Seong Woong; Park, Yoon Ghil; Cho, Sung-Rae; Lee, Won Taek; Lee, Jongeun; Nam, Chung Mo; Han, Kyung Hwa; Park, Eun Sook.

In: Developmental Medicine and Child Neurology, Vol. 53, No. 4, 01.04.2011, p. 327-333.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of constraint-induced movement therapy on neurogenesis and functional recovery after early hypoxic-ischemic injury in mice

AU - Rha, Dong Wook

AU - Kang, Seong Woong

AU - Park, Yoon Ghil

AU - Cho, Sung-Rae

AU - Lee, Won Taek

AU - Lee, Jongeun

AU - Nam, Chung Mo

AU - Han, Kyung Hwa

AU - Park, Eun Sook

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Aim: Constraint-induced movement therapy (CIMT) has emerged as a promising therapeutic strategy for improving affected upper limb function in children with hemiplegic cerebral palsy (CP). However, little is known about the changes in the brain that are induced by CIMT. This study was designed to investigate these changes and behavioural performance after CIMT intervention in mice with neonatal hypoxic-ischemic brain injury. Method: We utilized the neonatal hypoxic-ischemic brain injury model established in mice pups. Three weeks after the injury, the mice were randomly assigned to the following three groups: the control group (n=15), the enriched-environment group (n=17), and the CIMT with an enriched-environment group (CIMT-EE, n=15). 5-bromo-2-deoxyuridine (BrdU) was injected daily to label proliferating cells during the 2 weeks of intervention. Results: The CIMT-EE group showed better fall rate in the horizontal ladder rung walking test (mean 5.4%, SD 3.6%) than either the control (mean 14.3%, SD 7.3%; p=0.001) or enriched-environment (mean 12.4%, SD 7.7%; p=0.010) groups 2 weeks after the end of intervention. The CIMT-EE group also showed more neurogenesis (mean 7069 cells/mm3, SD 4017 cells/mm3) than either the control group (mean 1555 cells/mm3, SD 1422 cells/mm3; p<0.001) or enriched-environment group (mean 2994 cells/mm3, SD 3498 cells/mm3; p=0.001) in the subventricular zone. In the striatum, neurogenesis in the CIMT-EE group (mean 534 cells/mm3, SD 441 cells/mm3) was greater than in the control group (mean 95 cells/mm3, SD 133 cells/mm3; p=0.001). Interpretation: There was CIMT-EE enhanced neurogenesis in the brain along with functional benefits in mice after early hypoxic-ischemic brain injury. This is the first study to demonstrate the effects of CIMT on neurogenesis and functional recovery after experimental injury to an immature brain.

AB - Aim: Constraint-induced movement therapy (CIMT) has emerged as a promising therapeutic strategy for improving affected upper limb function in children with hemiplegic cerebral palsy (CP). However, little is known about the changes in the brain that are induced by CIMT. This study was designed to investigate these changes and behavioural performance after CIMT intervention in mice with neonatal hypoxic-ischemic brain injury. Method: We utilized the neonatal hypoxic-ischemic brain injury model established in mice pups. Three weeks after the injury, the mice were randomly assigned to the following three groups: the control group (n=15), the enriched-environment group (n=17), and the CIMT with an enriched-environment group (CIMT-EE, n=15). 5-bromo-2-deoxyuridine (BrdU) was injected daily to label proliferating cells during the 2 weeks of intervention. Results: The CIMT-EE group showed better fall rate in the horizontal ladder rung walking test (mean 5.4%, SD 3.6%) than either the control (mean 14.3%, SD 7.3%; p=0.001) or enriched-environment (mean 12.4%, SD 7.7%; p=0.010) groups 2 weeks after the end of intervention. The CIMT-EE group also showed more neurogenesis (mean 7069 cells/mm3, SD 4017 cells/mm3) than either the control group (mean 1555 cells/mm3, SD 1422 cells/mm3; p<0.001) or enriched-environment group (mean 2994 cells/mm3, SD 3498 cells/mm3; p=0.001) in the subventricular zone. In the striatum, neurogenesis in the CIMT-EE group (mean 534 cells/mm3, SD 441 cells/mm3) was greater than in the control group (mean 95 cells/mm3, SD 133 cells/mm3; p=0.001). Interpretation: There was CIMT-EE enhanced neurogenesis in the brain along with functional benefits in mice after early hypoxic-ischemic brain injury. This is the first study to demonstrate the effects of CIMT on neurogenesis and functional recovery after experimental injury to an immature brain.

UR - http://www.scopus.com/inward/record.url?scp=79952585914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952585914&partnerID=8YFLogxK

U2 - 10.1111/j.1469-8749.2010.03877.x

DO - 10.1111/j.1469-8749.2010.03877.x

M3 - Article

VL - 53

SP - 327

EP - 333

JO - Developmental Medicine and Child Neurology

JF - Developmental Medicine and Child Neurology

SN - 0012-1622

IS - 4

ER -